On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Dana-Farber Brigham Cancer Center

InstitutionResearch output, impact & collaborations

Dana-Farber Brigham Cancer Center is a institution indexed in ScholarIQ from OpenAlex.

What is known about Dana-Farber Brigham Cancer Center?

ScholarIQrecord summary

Dana-Farber Brigham Cancer Center is a research organisation in Boston, US. OpenAlex records 11,666 works and 2,404,563 citations for it. 1,805 researchers list it as their most recent affiliation.

How many works does Dana-Farber Brigham Cancer Center have?

ScholarIQindexed works

Dana-Farber Brigham Cancer Center has 11,666 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Dana-Farber Brigham Cancer Center →

How many citations does Dana-Farber Brigham Cancer Center have?

ScholarIQcitation count

Dana-Farber Brigham Cancer Center has 2,404,563 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Dana-Farber Brigham Cancer Center →

How many researchers are at Dana-Farber Brigham Cancer Center?

ScholarIQresearcher count

Dana-Farber Brigham Cancer Center has 1,805 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Dana-Farber Brigham Cancer Center?

ScholarIQavg h-index

Dana-Farber Brigham Cancer Center has an average h-index of 87 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Dana-Farber Brigham Cancer Center?

ScholarIQror

The ROR for Dana-Farber Brigham Cancer Center is on the source record.

Open the ROR →

What is the OpenAlex record for Dana-Farber Brigham Cancer Center?

ScholarIQopenalex

The OpenAlex for Dana-Farber Brigham Cancer Center is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Dana-Farber Brigham Cancer Center?

ScholarIQtop researchers by citations

Gary M. Clark · Breast Cancer Treatment Studies

312 works56,511 citations

What are the most-cited papers on Dana-Farber Brigham Cancer Center?

ScholarIQmost cited works

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel Campos, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano Van Kooten, Mircea Dediu, B. Findlay, Dongsheng Tu, D. Johnston, Andrea Bezjak, Gary M. Clark, P. Santabárbara, Lesley Seymour

New England Journal of Medicine. 20055,459 CitationsOPEN ACCESS

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark

JNCI Journal of the National Cancer Institute. 20052,098 CitationsOPEN ACCESS

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, Gary M. Clark

British Journal of Cancer. 20051,398 CitationsOPEN ACCESS

Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene

Journal of Clinical Oncology. 20021,184 Citations

Prognostic Factors in Breast Cancer

Patrick L. Fitzgibbons, David L. Page, Donald L. Weaver, Ann D. Thor, D. Craig Allred, Gary M. Clark, Stephen G. Ruby, Frances P. O’Malley, Jean F. Simpson, James L. Connolly, Daniel F. Hayes, Stephen B. Edge, Allen S. Lichter, Stuart J. Schnitt

Archives of Pathology & Laboratory Medicine. 20001,072 Citations

How much of the research on Dana-Farber Brigham Cancer Center is open access?

ScholarIQopen access share

50%OPEN ACCESS

Gold

Green

Hybrid

13%

Bronze

38%

Closed

50%